A Study to Assess the Efficacy of Inhaled Corticosteroid (ICS) Therapy in Moderate-Severe Bronchial Asthma

Status:
Completed

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

The purpose of this study is to investigate/assess the treatment of moderate to severe asthmatics with inhaled corticosteroid.

Phase 1/Phase 2

Novartis